The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
Updated daily with latest market intelligence
Pharmaceuticals
BioPharmaceuticals Next
BioPharmaceuticals Next Secures $1.6B Series E to Lead Pharmaceuticals Innovation
BioPharmaceuticals Next raises $1.6B in Series E funding at $24.3B valuation to advance 12 drug candidates through clinical trials, scale gene therapy manufacturing, and expand personalized medicine programs.
Editorial Team
Sep 20, 2025
2 min read•$1.6B
AI Drug Discovery
AIPharmacy Discovery
AIPharmacy Discovery Raises $1.1B Series E for Revolutionary AI Drug Discovery Technology
AIPharmacy Discovery secures $1.1B in Series E funding at $16.8B valuation to pioneer breakthrough ai drug discovery technology.
Editorial Team
Sep 27, 2025
2 min read•$1.1B
Genomics
23andMe
23andMe transforms genomics industry with $300M Series F at $3.5B valuation
23andMe achieves $3.5B valuation through $300M Series F funding, establishing dominance in the genomics market with innovative direct-to-consumer genetic testing and research platform.
Sarah Torres
Jun 10, 2025
8 min read•$300M
Showing 3 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.